Videos

Deborah Stephens, DO, Huntsman Cancer Institute, University of Utah, discusses her presentation from the 2023 NCCN Annual Conference on the use of nicotinamide to prevent nonmelanoma skin cancers in patients with chronic lymphocytic leukemia.

Dr Daniel Virnich, President, The Oncology Institute, discusses his presentation on drug cost support and funding programs for patients with cancer from Oncology at Total Health 2022.

At the 2022 Lymphoma, Leukemia & Myeloma Congress in New York, Javid Moslehi, University of California San Francisco, San Francisco, CA, discussed the cardiovascular risks associated with utilization of BTK inhibitors for patients with...

Tom Hutson, DO, PharmD, Texas A&M College of Medicine, discusses his presentation from the 2023 ASCO Genitourinary Symposium, which analyzed the use of nivolumab plus cabozantinib versus sunitinib for treating patients with renal cell...

Tejas Patil, MD, University of Colorado Cancer Center, discusses recent developments in the treatment landscape for patients with ALK-positive NSCLC and how clinical pathways can help standardize the treatment practices for these patients.

Dr Rana McKay, MD, Associate Professor of Medicine at the University of California San Diego, discusses the findings from her study, "Characterization of FOLH1 expression in renal cell carcinoma."

Efficacy and Safety of Parsaclisib Add-on to Ruxolitinib in Patients With Myelofibrosis: Final Results From a Phase 2 Study from HMP on Vimeo. At the 2022 ASH Annual Meeting and Exposition in New Orleans, LA, Abdulraheem Yacoub, MD,...

Adria Warren, health care transactional partner at Foley & Lardner LLP, spoke with the Journal of Clinical Pathways about new developments in the 340B drug pricing program and provided updates on recent court rulings and cases in process that...

Andre Harvin, PharmD, MS, MBA, discusses controlling costs in the business of oncology through biosimilar use.